Osorio JH, Pourfarzam M
5-7,9 Detecting Insulin Resistance Not surprisingly, obesity, particularly high visceral or abdominal fat, is the greatest risk factor for insulin resistance and type 2 diabetes
10.1001/jama.2018.18269 Summary Keywords acarbose, dipeptidyl peptidase-4 inhibitors, glucose-lowering efficacy, network meta-analysis, randomized controlled trials, tolerability and safety issue, type 2 diabetes, weight-loss effect Citation Zhang F, Xu S, Tang L, Pan X and Tong N (2020) Acarbose With Comparable Glucose-Lowering but Superior Weight-Loss Efficacy to Dipeptidyl Peptidase-4 Inhibitors: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
This refers to the amount of time it takes for half of the drug to be eliminated from the body
Reprod Sci (2015) 22:78390
Handog E